1st Quarter - Report

MEDLINE for MEDLINE

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Tariff (miscellaneous tariff bills) TAR

Section 301 tariffs, exclusions and compliance, S. 1260 United States Innovation and Competition Act of 2021 concerning Section 301 tariffs

LobbyistCovered position, as disclosed
AARON ROSS WINTERS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 1260 (117th)

Health Issues HCR

Healthcare supply chain, resiliency and product continuity

LobbyistCovered position, as disclosed
AARON ROSS WINTERS —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Environment/Superfund ENV

Medical device sterilization

LobbyistCovered position, as disclosed
AARON ROSS WINTERS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Environmental Protection Agency (EPA); Food & Drug Administration (FDA)

Trade (domestic/foreign) TRD

Healthcare supply chain and resiliency

LobbyistCovered position, as disclosed
AARON ROSS WINTERS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.